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INTRODUCTION 
• Genetically Modified Organisms: any organism, 
plant or animal which genetic material has 
been modified not by natural recombination or 
reproduction. 
• Living Modified Organisms: any organism, plant 
or animal which genetic material has been 
modified not by natural recombination or 
reproduction, which is capable of replication. 
INTRODUCTION 
Genetically Modified (GM) products have increased on 
the market as foods and food additives, beverages, 
fuels and pharmaceutical products since the 1990’s 
but there are concerns about potential side effects on 
human health and the environment.  
From 1.7 million hectares of GM crops cultivated in 
1996, this multi-billion-dollar global industry has 
increased to 160 million hectares in 2011.  
AT THE INTERNATIONAL LEVEL 
 1992 Rio Summit: Agenda 21 (chapter 16) 
 The 1992 Convention on Biodiversity (CBD) includes 
international rules on access to genetic resources and 
transfer of biotechnology techniques but no detailed 
regulation on Genetically Modified Organisms (GMOs).  
 The 2000 Cartagena Protocol on the safety of 
transboundary movements of Living Modified Organisms 
(LMOs), (Cartagena Protocol). 
 The 2010 Nagoya-Kuala Lumpur Supplementary Protocol 
on liability and redress for damages resulting from 
transboundary movements of LMOs (the Nagoya 
Supplementary Protocol). 
 
KEY ISSUES TO BE ADDRESSED 
 The scope of the GMOs to be regulated 
 Identification and traceability issues 
 The relationship of the Cartagena Protocol with other 
prior international agreements 
 Liability and redress issues 
 Harmonisation of biosafety regulation issues 
 Other issues (socio-economic considerations, risk 
assessment and risk management, financial 
guarantees, compliance…) 
SCOPE OF THE GMOS COVERED 
 
 Only LMOs (but not GMOs) are covered by the 
Cartagena Protocol and the Nagoya Supplementary 
Protocol. 
 LMOs to be released into the environment (GM 
seeds). 
 LMOs destined for contained use (GM viruses or 
bacteria). 
 LMOs intended for direct use as food, feed or to be 
processed (live GM salmon, GM grains intended for 
feed) but there is no compliance mechanism as to the 
final use of this category. GM food aid? 
GMOS WHICH ARE NOT COVERED  
LMOs to be used as raw material for the 
production of pharmaceuticals. 
GM agricultural products with added health value 
(nutraceuticals such as rice with enriched 
vitamins) or GM products modified as edible 
vaccines. 
GM additives and flavourings (GM strawberry). 
Products derived from LMOs to be used directly as 
food and feed (oil, flour, tomato sauce, chicken 
eggs from chicken fed with GM feed) which cannot 
replicate themselves or transfer genetic material. 
 
 
SCOPE OF THE ADVANCE INFORMED AGREEMENT 
PROCEDURE 
 
 Not subjected to the AIA procedure: 
 Pharmaceuticals to be used by human beings which 
are subjected to other agreements or relevant 
international organisations are not subjected to the 
AIA procedure however these instruments may deal 
with human health concerns but do not address 
directly the environmental and biodiversity impacts of 
LMOs. 
 
SCOPE OF THE ADVANCED INFORMATION AGREEMENT 
PROCEDURE 
 
 Not subjected to the AIA procedure: 
 LMOs in contained use. 
 LMOs in transit (only placed under customs 
procedures applicable in different States).  
 LMOs to be used as food and feed or food to be 
processed. 
 Simplified procedures for LMOs considered as less 
dangerous (Articles 11 and 13 of the Cartagena 
Protocol). 
 
 
 
MAIN ISSUES ABOUT LABELLING  AND 
TRACEABILITY: 
 
 Whether the labelling of GM products must be 
mandatory or voluntary? No international labelling 
obligation. 
 Which products should be labelled and the contents 
of the labels? 
 Whether traces of GM content in the final product 
must be labelled and at which thresholds? No 
international threshold on the labelling of GM 
products. 
IDENTIFICATION AND TRACEABILITY ISSUES 
 Labelling obligation in the protocol only for 
LMOs intended for direct use as food and feed 
or to be processed (Annexure II of the 
Cartagena Protocol).  
 No official inspection mechanism for this 
labelling obligation. 
 Grain shippers have been using the “may 
contain LMOs” designation on commercial 
invoices. 
 
 
IDENTIFICATION AND TRACEABILITY ISSUES 
 
 No international labelling obligation amounts to: 
 Different standards in different countries.  
 Consequences on the organic products’ industry. 
 No segregation and risks of mixing GM and non-GM 
products during transboundary movements. 
 Lack of traceability of GM products in case of health 
hazards or unintentional release into the environment. 
 
RELATIONSHIP OF THE BIOSAFETY PROTOCOL WITH 
OTHER PRIOR INTERNATIONAL AGREEMENTS 
 The WTO Agreement on the application of Sanitary and 
Phytosanitary Measures (the SPS Agreement). 
 The WTO Agreement on Technical Barriers to Trade 
(TBT Agreement). 
 The General Agreement on Tariff and Trade (GATT) 
1994 
 The WTO Reference bodies (Codex Alimentarius, World 
Health Organisation (WHO), World organisation for 
Animal Health (OIE)). 
 The International Plant Protection Convention (IPPC) 
 
RELATIONSHIP OF THE BIOSAFETY PROTOCOL WITH 
OTHER PRIOR INTERNATIONAL AGREEMENTS  
 Existence of a saving Clause in the Cartagena Protocol stating 
that it is not subordinate or superior to other prior international 
instruments. 
 The Cartagena Protocol applies only to LMOs whereas the trade 
agreements apply to all categories of GMOs. 
 But the Cartagena Protocol fully applies to a transboundary 
movement of LMOs for non-commercial purposes.  
 The Cartagena Protocol rests on the Precautionary principle 
whereas the trade agreements apply the principle of 
substantial equivalence. 
 Which standards will apply in case of international trade of 
GMOs and which dispute settlement mechanism will apply? 
 
 
LIABILITY AND REDRESS ISSUES 
 The Nagoya-Kuala Lumpur Supplementary Protocol 
2010 sets up mainly administrative and civil liability 
rules and procedures to be implemented by States 
Parties.   
 The national competent authority of the country 
affected by the damage needs to investigate the 
matter, evaluate the damage and determine which 
response measures need to be taken by the operator. 
 
LIABILITY AND REDRESS ISSUES 
 Standard of civil liability (fault-based or strict liability) 
for damages resulting from transboundary movements 
of LMOs. 
 Causal link (the burden of proof will be different 
depending on whether a fault-based or strict liability is 
applicable).    
 Damages (adverse effects on the sustainable use of 
biological diversity taking into account human health) 
 Exemption to liability (acts of war and civil unrest) 
 Which dispute settlement procedures will apply? 
HARMONISATION OF BIOSAFETY REGULATION 
ISSUES  
 Increase of national biosafety frameworks 
(NBFs) since the adoption of the Cartagena 
Protocol (in 2012, 118 States have NBFs). 
 Influence of weaker or stronger regional 
biosafety mechanisms. 
 Influence of the biotech industry for weaker 
mechanisms. 
 Bilateral or multilateral agreements.  
 
 
OTHER ISSUES 
 Socio-economic considerations (SA communication on 
GM crops’ impact on small-scale farmers, Indian 
farmers and the negative effects of using corporate GM 
seeds instead of farm-saved seeds?)  
 Risk assessment and risk management (which 
methods, sound science?) 
 Compliance (reporting, Biosafety Clearing House 
(BCH..) 
 Financial guarantees in relation to transboundary 
movements of LMOs. 
CONCLUSION 
 The Cartagena Protocol provides for a baseline of legal 
control on the import and export of GMOs that needs 
to be translated into national regimes. 
 Additional categories of GMOs need to be regulated 
since the Cartagena Protocol was drafted targetting 
mainly GM agricultural products.  
 Need for a better control of illegal movement of GMOs 
considered as hazardous (pathogenic GM 
microorganisms) for public health or security 
(bioterrorism).  
CONCLUSION 
 Need for harmonisation of standards : different standards 
applicable for different countries resulting in a less efficient 
biosafety system. 
 Harmonisation of identification and traceability standards, risk 
assessment and risk management standards and 
communication of information on biotechnological risks.  
 Harmonisation with inter-State cooperation (at best by 
competent international bodies) and not by influential private 
actors with vested interests.  
 
 
CONCLUSION 
 Need for an international liability and redress regime. 
 Procedures to bring redress depend too much on the area in 
which the damage occurred and domestic laws on liability . 
 Damages caused to the neighbouring areas and their biological 
diversity may be irreversible and there is no redress for damages 
in areas beyond national jurisdiction.  
 20 years after Rio, existing biosafety instruments represent 
milestones paving the way ahead. These  existing biosafety 
instruments need to be deepened and implemented at the 
national level for more efficiency rather than elaborating more 
instruments. 
 
 
 
Thank you for your attention. 
